US2017202910A1PendingUtilityA1

Differentiation marker and differentiation control of eye cell

Assignee: KYOTO PREFECTURAL PUBLIC UNIV CORPPriority: Jul 6, 2012Filed: Feb 27, 2017Published: Jul 20, 2017
Est. expiryJul 6, 2032(~6 yrs left)· nominal 20-yr term from priority
G01N 2800/16A61K 38/00A61K 48/00C07K 14/705G01N 2333/726C12N 5/0621A61K 35/30C12N 2501/415C12N 2501/40C12Q 1/6881C12Q 2600/158A61K 38/1709A61P 27/02G01N 33/56966
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a differentiation marker and a differentiation controlling technique for an eye cell. More particularly, the present invention has attained an object of providing a differentiation marker for an eye cell among the aforementioned problems, by providing a marker for identifying a cell having a high proliferation ability among corneal endothelial cells and/or the differentiation ability of a corneal endothelial cell, the marker comprising GPR49/LGR5, as well as a detection agent or detection method for identifying a cell having a high proliferation ability among corneal endothelial cells and/or the differentiation ability of a corneal endothelial cell, comprising a substance binding to GPR49/LGR5. In addition, the present invention has attained an object of providing a differentiation controlling technique for an eye cell, by providing an agent for suppressing differentiation and/or promoting proliferation of an eye cell, comprising R-spondins.

Claims

exact text as granted — not AI-modified
1 )- 11 ) (canceled) 
     
     
         12 ) A method for treating a corneal endothelial cell disorder or preventing the progression of a corneal endothelial cell disorder in a subject, comprising administering one or more R-spondins or a functional equivalent thereof to the subject. 
     
     
         13 )- 37 ) (canceled) 
     
     
         38 ) The method according to claim  1 , wherein the R-spondins comprise one or more R-spondins selected from R-spondin 1, R-spondin 2, R-spondin 3, R-spondin 4 and combinations thereof. 
     
     
         39 ) The method according to claim  1 , wherein the R-spondins comprise R-spondin 1.

Join the waitlist — get patent alerts

Track US2017202910A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.